Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment

Stefan, Norbert; Yki-Jaervinen, Hannele; Neuschwander-Tetri, Brent

dc.contributor.author	Stefan, Norbert
dc.date.accessioned	2026-02-02T06:36:34Z
dc.date.available	2026-02-02T06:36:34Z
dc.date.issued	2025
dc.identifier.issn	2213-8587
dc.identifier.uri	http://hdl.handle.net/10900/174518
dc.language.iso	en	de_DE
dc.publisher	New York : Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S2213-8587(24)00318-8	de_DE
dc.subject.ddc	610	de_DE
dc.title	Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01971
utue.publikation.seiten	134-148	de_DE
utue.personen.roh	Stefan, Norbert
utue.personen.roh	Yki-Jaervinen, Hannele
utue.personen.roh	Neuschwander-Tetri, Brent
dcterms.isPartOf.ZSTitelID	Lancet Diabetes & Endocrinology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE